Frontiers in Digital Health is an innovative peer-reviewed journal published by FRONTIERS MEDIA SA, focusing on the intersection of digital technology and healthcare. As an Open Access journal since 2020, it aims to democratize knowledge by making cutting-edge research freely available to the global community. The journal covers a wide array of topics within the realms of Biomedical Engineering, Health Informatics, and a variety of Computer Science Applications, ensuring interdisciplinary collaboration and advancements. Recognized for its excellence, it holds prestigious rankings in multiple categories, including Q1 in Biomedical Engineering and Q2 in several related fields according to the 2023 metrics. Set in the heart of Switzerland, the journal fosters a comprehensive approach to enhancing digital health technologies, making it an essential resource for researchers, professionals, and students dedicated to improving health outcomes through innovation.

Healthcare Informatics Research, published by the Korean Society of Medical Informatics, is a leading open access journal that has been advancing the field of healthcare informatics since its inception in 2010. With an ISSN of 2093-3681 and E-ISSN of 2093-369X, the journal provides a vital platform for disseminating high-quality research aimed at improving healthcare systems through innovative informatics solutions. Recognized for its contributions, it holds a Q2 rank in Biomedical Engineering and Q3 rankings in both Health Informatics and Health Information Management for 2023, reflecting its stature within the academic community. The journal is committed to open access, ensuring that research is freely accessible to researchers, professionals, and students worldwide, thus promoting knowledge sharing and collaboration. Located in the dynamic city of Seoul, South Korea, the journal serves as a hub for groundbreaking studies that impact health systems globally, making it an essential resource for those at the forefront of healthcare technology and management.

Asia-Pacific Journal of Clinical Oncology is an essential publication within the field of medical oncology, dedicated to advancing the understanding and treatment of cancer through rigorous research and innovative clinical practices. Published by WILEY, this journal has established itself as a significant resource for researchers, healthcare professionals, and students interested in the latest findings across the Asia-Pacific region and beyond. With a respectable impact factor and categorized within the Q2 and Q3 quartiles of Medicine (miscellaneous) and Oncology respectively, the journal aims to disseminate knowledge on diverse aspects of clinical oncology, promoting the improvement of patient care and treatment outcomes. The Asia-Pacific Journal of Clinical Oncology, operating from the United Kingdom, invites contributions that highlight significant findings and advancements in oncology, making it a crucial platform for collaboration and knowledge sharing in this vital field of medicine.

JCO Oncology Practice is a premier peer-reviewed journal published by Lippincott Williams & Wilkins, specializing in the intersection of oncology and health policy. Established as a vital resource since 2020, this journal serves as a platform for the dissemination of innovative research, policy analysis, and clinical practice advancements aimed at enhancing cancer care. With its impressive impact factor and recognition in the top quartile (Q1) across multiple categories including Health Policy and Oncology, JCO Oncology Practice ranks #3 in Oncology Nursing and consistently shares cutting-edge insights that drive improvements within the field. The journal is accessible to a broad audience through its open access options, ensuring that vital knowledge reaches practitioners, researchers, and students alike. By prioritizing the latest evidence-based practices and addressing contemporary challenges in cancer treatment, JCO Oncology Practice plays an essential role in shaping the future of oncology practice and policy in the United States and beyond.

Journal of the Egyptian National Cancer Institute, published by SPRINGER, serves as a vital platform for disseminating innovative research in the field of oncology and cancer research. With both ISSN 1110-0362 and E-ISSN 2589-0409, this Open Access journal has been committed to making significant contributions to the scientific community since its inception in 2005. Operating from its base in Egypt, it has established itself as an important resource for researchers, practitioners, and students alike, offering insights into contemporary issues and advancements in cancer care. Recognized in the 2023 category quartiles as Q3 in Cancer Research and Q3 in Oncology, the journal is positioned to impact the ongoing discourse in cancer treatment strategies and health policy. As it continues to publish peer-reviewed articles through available Open Access avenues, the Journal of the Egyptian National Cancer Institute remains dedicated to enhancing the knowledge base and collaborative efforts within the global cancer research community.

JMIR Research Protocols, published by JMIR PUBLICATIONS, INC, is a leading open-access journal that has been at the forefront of advancing research methodologies since its inception in 2012. With its ISSN 1929-0748, this journal is dedicated to providing a platform for the publication of innovative study protocols in the field of medicine, ensuring rigorous peer review and promoting transparency in research practices. Based in Canada, the journal has steadily gained recognition, currently holding a prominent position in the Q3 category of Medicine (Miscellaneous), with an impressive Scopus rank of #211 out of 636, placing it in the 66th percentile of its field. Researchers and professionals will find that JMIR Research Protocols not only supports the open sharing of knowledge but also enhances collaboration among the scientific community. Its open-access policy ensures broader dissemination of research findings, making it an essential resource for anyone interested in the evolving landscape of medical research methodologies.

Digital Health is a pioneering open-access journal published by SAGE Publications Ltd, dedicated to advancing the field of health technology and its intersection with health policy, informatics, and the broader medical landscape. Since its inception in 2015, the journal has rapidly established itself as an essential resource for researchers, professionals, and students, serving as a platform for innovative research that leverages digital tools to improve health outcomes. Currently ranked in the Q2 category across four relevant domains, including Computer Science Applications and Health Informatics, it commands respect within the academic community. With its accessible framework, Digital Health facilitates the dissemination of critical findings and new methodologies that inform policy and practice. The journal’s commitment to open access promotes worldwide access and cooperation, making significant contributions to the evolving landscape of digital health.

Welcome to the International Journal of E-Health and Medical Communications, a pivotal publication designed to bridge the gap between health informatics and computer science applications. Published by IGI Global, this journal serves as a platform for innovative research and insights into e-health technologies, health communication strategies, and the evolving role of digital tools in enhancing healthcare delivery and management. With an ISSN of 1947-315X and E-ISSN 1947-3168, it caters to an audience keen on advancing the intersection of technology and health, as evidenced by its respectable standings in Scopus rankings—positioned in the 64th percentile in Health Informatics and 63rd in Computer Science Applications. Over its publication history from 2010 to 2024, the journal has consistently contributed to significant discussions and advancements within these fields, highlighted by its Q3 quartile ranking in 2023. Join a community of researchers, professionals, and students dedicated to the ongoing exploration of e-health, as we collectively navigate the complex landscape of healthcare innovation.

The Lancet Oncology is a premier peer-reviewed journal published by Elsevier Science Inc., recognized as a leading authority in the field of oncology. With an ISSN of 1470-2045 and E-ISSN 1474-5488, this esteemed journal boasts an impressive 2023 impact factor placing it in the Q1 category of oncology—reflecting its role as a critical resource for cutting-edge research. The journal publishes high-quality articles covering novel scientific discoveries, clinical advancements, and public health issues related to cancer treatment and prevention. It is ranked #5 out of 404 in the Scopus Medicine _ Oncology category, demonstrating its influence and relevance in the field, with an outstanding rank in the 98th percentile. Operating from its base in the United Kingdom, The Lancet Oncology spans a comprehensive timeframe from 2000 to 2024, making it a vital repository of oncology literature. Although it does not primarily operate on an open-access model, its significant subscription base ensures that a wealth of knowledge is accessible to researchers, professionals, and students alike, fostering a profound understanding and advancement in oncology.

The Lancet Respiratory Medicine, published by Elsevier in the United Kingdom, is a premier journal dedicated to the field of pulmonary and respiratory medicine. With its impressive impact factor and a prestigious ranking of #1 out of 155 in its category as of 2023, it holds a remarkable position in advancing research and clinical practices in respiratory health. The journal invites original research, reviews, and clinical studies that aim to propel the understanding of respiratory diseases, fostering innovations in treatment and management strategies. Operating under a Q1 category in Scopus rankings, it is an essential platform for researchers, healthcare professionals, and students who are committed to enhancing patient care and advancing knowledge in this crucial area of medicine. The Lancet Respiratory Medicine remains a vital resource for the latest findings and discussions shaping the future of respiratory health.